BCR-ABL1 transcript at 3 months predicts long-term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed Imatinib

✍ Scribed by Kim, Dennis D.; Lee, Honggi; Kamel-Reid, Suzanne; Lipton, Jeffrey H.

• Book ID: 121801463
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 351 KB
• Volume: 160
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/bjh.12187